PRQR
ProQR Therapeutics NV
NASDAQ · Healthcare · Biotechnology · NL
$1.42
+3.28%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 12.38x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.25x
- Price / sales
- 9.61x
- Price / cash flow
- -3.63x
Enterprise value
- Enterprise value
- $83.4M
- EV / sales
- 4.01x
- EV / EBITDA
- -1.98x
- EV / EBIT
- -1.72x
- Market cap
- $199.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026